Related Experiment Videos
Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation
1Integrated Program in Molecular, Cellular, and Biophysical Studies, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
Abstract:
In Abelson murine leukemia virus (A-MuLV)-transformed cells, members of the Janus kinase (Jak) family of non-receptor tyrosine kinases and the signal transducers and activators of transcription (STAT) family of signaling proteins are constitutively activated. In these cells, the v-Abl oncoprotein and the Jak proteins physically associate. To define the molecular mechanism of constitutive Jak-STAT signaling in these cells, the functional significance of the v-Abl-Jak association was examined. Mapping the Jak1 interaction domain in v-Abl demonstrates that amino acids 858 to 1080 within the carboxyl-terminal region of v-Abl bind Jak1 through a direct interaction. A mutant of v-Abl lacking this region exhibits a significant defect in Jak1 binding in vivo, fails to activate Jak1 and STAT proteins, and does not support either the proliferation or the survival of BAF/3 cells in the absence of cytokine. Cells expressing this v-Abl mutant show extended latency and decreased frequency in generating tumors in nude mice. In addition, inducible expression of a kinase-inactive mutant of Jak1 protein inhibits the ability of v-Abl to activate STATs and to induce cytokine-independent proliferation, indicating that an active Jak1 is required for these v-Abl-induced signaling pathways in vivo. We propose that Jak1 is a mediator of v-Abl-induced STAT activation and v-Abl induced proliferation in BAF/3 cells, and may be important for efficient transformation of immature B cells by the v-abl oncogene.
Insights
The Abelson murine leukemia virus oncoprotein v-Abl directly binds and activates Janus kinase 1 (Jak1), which is crucial for Signal Transducer and Activator of Transcription (STAT) signaling, cell proliferation, and tumor formation.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Abelson murine leukemia virus (A-MuLV) transformation involves constitutive activation of Janus kinase (Jak) and Signal Transducer and Activator of Transcription (STAT) proteins.
- The v-Abl oncoprotein physically associates with Jak proteins in transformed cells.
Purpose of the Study:
- To elucidate the molecular mechanism of constitutive Jak-STAT signaling in A-MuLV-transformed cells.
- To investigate the functional significance of the v-Abl-Jak association.
Main Methods:
- Mapping the Jak1 interaction domain within the v-Abl carboxyl-terminal region (amino acids 858-1080).
- Utilizing v-Abl mutants lacking the Jak1 binding domain.
- Assessing Jak1 and STAT activation, BAF/3 cell proliferation and survival, and tumor formation in nude mice.
- Inducible expression of a kinase-inactive Jak1 mutant.
Main Results:
- A direct interaction between v-Abl (amino acids 858-1080) and Jak1 was identified.
- A v-Abl mutant lacking this region showed impaired Jak1 binding, failed to activate Jak1 and STATs, and did not support cytokine-independent proliferation or survival of BAF/3 cells.
- Cells expressing the v-Abl mutant exhibited delayed tumor formation in vivo.
- Inhibition of Jak1 activity blocked v-Abl-induced STAT activation and proliferation.
Conclusions:
- Jak1 acts as a mediator of v-Abl-induced STAT activation and proliferation in BAF/3 cells.
- The v-Abl-Jak1 interaction is essential for v-Abl-mediated transformation of immature B cells.